EPRX holders · CITADEL ADVISORS LLC 13F · EPRX stock
CITADEL ADVISORS LLC Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) 13F holding
CITADEL ADVISORS LLC reported 230,176 EPRX shares valued at $1.7M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.
This is the newest EPRX 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the EPRX holders table.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-03-31 | 230,176 | $1.7M | COM |
| 2025-06-30 | 18,236 | $108.0K | COM |
Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.